Jo Ishizawa

2.3k total citations
65 papers, 892 citations indexed

About

Jo Ishizawa is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Jo Ishizawa has authored 65 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 24 papers in Oncology and 24 papers in Hematology. Recurrent topics in Jo Ishizawa's work include Acute Myeloid Leukemia Research (18 papers), Cancer-related Molecular Pathways (13 papers) and Protein Degradation and Inhibitors (9 papers). Jo Ishizawa is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Cancer-related Molecular Pathways (13 papers) and Protein Degradation and Inhibitors (9 papers). Jo Ishizawa collaborates with scholars based in United States, Japan and Germany. Jo Ishizawa's co-authors include Michael Andreeff, Kensuke Kojima, Yoko Tabe, Vivian Ruvolo, Numsen Hail, Sharon Shacham, Shinya Kimura, Hideyuki Saya, R. Eric Davis and Hong Mu and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Jo Ishizawa

58 papers receiving 886 citations

Peers

Jo Ishizawa
Amit J. Sabnis United States
A M Martelli Italy
W. Brian Dalton United States
Vadym Zaberezhnyy United States
Grace R. Anderson United States
Marta Sánchez-Martín United States
Kym L. Stanley Australia
Homare Eda United States
Matthew A. Lawlor United States
Brian Freie United States
Amit J. Sabnis United States
Jo Ishizawa
Citations per year, relative to Jo Ishizawa Jo Ishizawa (= 1×) peers Amit J. Sabnis

Countries citing papers authored by Jo Ishizawa

Since Specialization
Citations

This map shows the geographic impact of Jo Ishizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Ishizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Ishizawa more than expected).

Fields of papers citing papers by Jo Ishizawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Ishizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Ishizawa. The network helps show where Jo Ishizawa may publish in the future.

Co-authorship network of co-authors of Jo Ishizawa

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Ishizawa. A scholar is included among the top collaborators of Jo Ishizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Ishizawa. Jo Ishizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Ran, Liang Zhang, Hiroki Akiyama, et al.. (2025). Protocol for isolation of lipid droplets and mitochondria from acute myeloid leukemia cells for lipidomic analysis. STAR Protocols. 6(4). 104257–104257.
2.
Zhang, Liang, Ran Zhao, Babita Kaundal, et al.. (2025). Ferroptosis activates NK and CAR T cell-mediated anti-tumor immunity in Acute Myeloid Leukemia. Blood. 146(Supplement 1). 1496–1496.
3.
Masárová, Lucia, Meixian Huang, Swati Goel, et al.. (2024). A phase Ib, open-label study of add-on therapy with CK0804 in participants with myelofibrosis and suboptimal response to ruxolitinib.. Journal of Clinical Oncology. 42(16_suppl). 6580–6580. 1 indexed citations
4.
Zhang, Liang, Ran Zhao, Hiroki Akiyama, et al.. (2024). Targeting Lipid Droplet Biogenesis to Enhance Ferroptosis in Acute Myeloid Leukemia. Blood. 144(Supplement 1). 1400–1400.
5.
6.
Ishizawa, Jo, Edward Ayoub, Muharrem Müftüoğlu, et al.. (2023). Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias. Science Advances. 9(48). eadh1436–eadh1436. 13 indexed citations
7.
8.
Akiyama, Hiroki, Ran Zhao, Ziyi Li, et al.. (2023). Mitochondrial regulation of GPX4 inhibition–mediated ferroptosis in acute myeloid leukemia. Leukemia. 38(4). 729–740. 27 indexed citations
9.
Nishida, Yuki, Ran Zhao, Lauren Heese, et al.. (2021). Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML. Leukemia. 35(9). 2469–2481. 25 indexed citations
10.
Piya, Sujan, Hong Mu, Seemana Bhattacharya, et al.. (2019). BETP degradation simultaneously targets acute myelogenous leukemic stem cells and the microenvironment. Journal of Clinical Investigation. 129(5). 1878–1894. 56 indexed citations
11.
Nii, Takenobu, Varun V. Prabhu, Vivian Ruvolo, et al.. (2019). Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia. Leukemia. 33(12). 2805–2816. 50 indexed citations
12.
Ishizawa, Jo, Kenji Nakamaru, Takahiko Seki, et al.. (2018). Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition. Cancer Research. 78(10). 2721–2731. 44 indexed citations
13.
14.
He, Jin, Huan Liu, Hans C. Lee, et al.. (2017). The Imipridone ONC201 Induces Apoptosis and Overcomes Chemotherapy Resistance by Up-Regulation of Bim in Multiple Myeloma. Neoplasia. 19(10). 772–780. 20 indexed citations
15.
Ishizawa, Jo, Kensuke Kojima, Teresa McQueen, et al.. (2015). Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs. PLoS ONE. 10(9). e0138377–e0138377. 21 indexed citations
16.
Tabe, Yoko, Kensuke Kojima, Shinichi Yamamoto, et al.. (2015). Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185. PLoS ONE. 10(9). e0137210–e0137210. 30 indexed citations
17.
Yokoyama, Kenji, Shinichiro Okamoto, Keiko Asakura, et al.. (2012). Post-transplant consolidation therapy using thalidomide alone for the patients with multiple myeloma: a feasibility study in Japanese population. International Journal of Hematology. 96(4). 477–484. 1 indexed citations
18.
Naoe, Hideaki, Tatsuyuki Chiyoda, Jo Ishizawa, et al.. (2012). The APC/C activator Cdh1 regulates the G2/M transition during differentiation of placental trophoblast stem cells. Biochemical and Biophysical Research Communications. 430(2). 757–762. 9 indexed citations
19.
Sugihara, Eiji, Takatsune Shimizu, Kensuke Kojima, et al.. (2011). Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor. Oncogene. 31(23). 2849–2861. 23 indexed citations
20.
Ishizawa, Jo, et al.. (2007). Quantification of Circulating Varicella-Zoster Virus DNA for Follow-up in a Case of Visceral Varicella-Zoster Infection Ameliorated with Intravenous Acyclovir. International Journal of Hematology. 85(3). 242–245. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amit J. Sabnis Breakdown of academic impact, for papers by A M Martelli Breakdown of academic impact, for papers by W. Brian Dalton Breakdown of academic impact, for papers by Vadym Zaberezhnyy Breakdown of academic impact, for papers by Grace R. Anderson Breakdown of academic impact, for papers by Marta Sánchez-Martín Breakdown of academic impact, for papers by Kym L. Stanley Breakdown of academic impact, for papers by Homare Eda Breakdown of academic impact, for papers by Matthew A. Lawlor Breakdown of academic impact, for papers by Brian Freie
Rankless by CCL
2026